Hunan Warrant Pharmaceutical Co. Ltd. A (688799) — Cash Flow Reinvestment Rate
Hunan Warrant Pharmaceutical Co. Ltd. A (688799) has a Cash Flow Reinvestment Rate of 4.17x as of December 2024, reinvesting CN¥592.69 Million (capex CN¥233.87 Million plus investments CN¥-358.82 Million) from operating cash flow of CN¥142.23 Million. Explore reinvestment intensity of Hunan Warrant Pharmaceutical Co. Ltd. A to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hunan Warrant Pharmaceutical Co. Ltd. A Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Hunan Warrant Pharmaceutical Co. Ltd. A across 6 annual periods. Also explore balance sheet size of Hunan Warrant Pharmaceutical Co. Ltd. A for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hunan Warrant Pharmaceutical Co. Ltd. A (2019–2024)
Year-by-year capital reinvestment analysis for Hunan Warrant Pharmaceutical Co. Ltd. A. For live market cap and broader valuation context, see how much is Hunan Warrant Pharmaceutical Co. Ltd. A worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.17x | CN¥592.69 Million | CN¥142.23 Million | CN¥233.87 Million | ▲ +516.8% |
| 2023 | 0.68x | CN¥144.89 Million | CN¥214.44 Million | CN¥105.76 Million | ▼ -71.0% |
| 2022 | 2.33x | CN¥362.47 Million | CN¥155.65 Million | CN¥131.85 Million | ▼ -56.2% |
| 2021 | 5.31x | CN¥609.40 Million | CN¥114.72 Million | CN¥92.10 Million | ▲ +383.9% |
| 2020 | 1.10x | CN¥114.89 Million | CN¥104.66 Million | CN¥53.75 Million | ▲ +158.5% |
| 2019 | 0.42x | CN¥49.55 Million | CN¥116.66 Million | CN¥24.34 Million | — |